Close Menu

NEW YORK (GenomeWeb) – DiaSorin Molecular announced today the US Food and Drug Administration has cleared the firm's Simplexa GBS Direct assay.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.